Medical Device Labeling Regulations; Unique Device Identification
Revision of a currently approved collection
No
Regular
Approved without change
03/31/2023
02/28/2023
Upon approval, the agency agrees to discontinue 0910-0614.
table that charts list comparision
Inventory as of this Action
Requested
Previously Approved
03/31/2026
36 Months From Approved
11/30/2025
318,776
0
2,625
420,567
0
104,370
10,100,000
0
10,100,000
This information collection request supports FDA implementation of statutory provisions under the Federal Food, Drug, and Cosmetic Act (FD&C Act) governing medical device labeling. We are revising the information collection to include burden that may be attributable to activities associated with provisions found in section 519(f) of the FD&C Act, implemented in 21 CFR part 830 (21 CFR 830), establishing the use of a Unique Device Identifier (UDI). These provisions were currently approved in OMB control no. 0910-0720 and established through rulemaking on September 24, 2013 (0910-AG31).
US Code:
21 USC 360i(f)
Name of Law: Unique Device Identification
We have adjusted our estimate to reflect an increase of 316,151 responses and 316,197 hours to account for program changes resulting from the implementation of rulemaking in 2007 and 2014 pertaining to SNS product labeling and UDI requirements, respectively.
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.